Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment

Leukemia. 2016 Jan;30(1):242-7. doi: 10.1038/leu.2015.122. Epub 2015 May 15.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / therapy*
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Leukemia, Myeloid, Acute / etiology*
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / therapy
  • Middle Aged
  • Myelodysplastic Syndromes / etiology*
  • Myelodysplastic Syndromes / mortality
  • Myelodysplastic Syndromes / therapy
  • Myelodysplastic-Myeloproliferative Diseases / etiology*
  • Myelodysplastic-Myeloproliferative Diseases / mortality
  • Myelodysplastic-Myeloproliferative Diseases / therapy
  • Neoplasms, Second Primary / etiology*
  • Neoplasms, Second Primary / mortality
  • Neoplasms, Second Primary / therapy
  • Proportional Hazards Models